Use of adhesion molecules for gene delivery

Experimental Nephrology

Volumn 7, Issue 2, 1999, Pages 193-199

  Hart, Stephen ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Gene therapy; Integrins; Liposomes; Non viral; Peptides; Targeting

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CELL ADHESION MOLECULE;

GENE TARGETING; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032896956     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020600     Document Type: Review

References (52)

1. Felgner PL, Barenholz Y, Behr JP, Cheng SH, Cullis P, Huang L, Jessee JA, Seymour L, Szoka F, Thierry AR, Wagner E, Wu G: Nomenclature for synthetic gene delivery systems. Hum Gene Ther 1997;8:511-512.
2. Hynes RO: Integrins: Versatility, modulation, and signalling in cell adhesion. Cell 1992;69: 11-25.
3. Isberg RR, Tran Van Nhieu G: Binding and internalization of microorganisms by integrin receptors. Trends Microbiol 1994;2:10-14.
4. Bai M, Harfe B, Freimuth P: Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J Virol 1993;67:5198-5205.
5. Bergelson JM, Shepley MP, Chan BMC, Hemler ME, Finberg RW: Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 1992;255:1718-1720.
6. Mason PW, Rieder E, Baxt B: RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc Natl Acad Sci USA 1994;91:1932-1936.
7. Isberg RR: Pathways for the penetration of enteroinvasive Yersinia into mammalian cells. Mol Biol Med 1990;7:73-82.
8. Isberg RR, Voorhis DL, Falkow S: Identification of invasin: A protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell 1987;50:769-778.
9. Leong JM, Fournier RS, Isberg RR: Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein. EMBO J 1990;9:1979-1989.
10. Leong JM, Morrissey PE, Isberg RR: A 76-amino-acid disulfide loop in the Yersinia pseudotuberculosis invasin protein is required for integrin receptor recognition. J Biol Chem 1993; 268:20524-20532.
11. Van Nhieu GT, Isberg RR: The Yersinia pseudotuberculosis invasin protein and human fibronectin bind to mutually exclusive sites on the alpha 5 beta 1 integrin receptor. J Biol Chem 1991;266:24367-24375.
12. Isberg RR: Discrimination between intracellular uptake and surface adhesion of bacterial pathogens. Science 1991;252:934-938.
13. Wagner E, Cotten M, Foisner R, Birnstiel ML: Transferrin-polycation-DNA complexes: The effect of polycations on the structure of the complex and DNA delivery to cells. Proc Natl Acad Sci USA 1991;88:4255-4259.
14. Wagner E, Zenke M, Cotten M, Beug H, Birnstiel ML: Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 1990;87:3410-3414.
15. Zenke M, Steinlein P, Wagner E, Cotten M, Beug H, Birnstiel ML: Receptor-mediated endocytosis of transferrin-polycation conjugates: An efficient way to introduce DNA into hematopoietic cells. Proc Natl Acad Sci USA 1990; 87:3655-3659.
16. Gotten M, Langle-Rouault F, Kirlappos H, Wagner E, Mechtler K, Zenke M, Beug H, Birnstiel ML: Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc Natl Acad Sci USA 1990;87:4033-4037.
17. Curiel DT, Agarwal S, Wagner E, Cotten M: Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci USA 1991;88:8850-8854.
18. Curiel DT, Wagner E, Cotten M, Birnstiel ML, Agarwal S, Li CM, Loechel S, Hu PC: High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Hum Gene Ther 1992;3:147-154.
19. Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML: Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene transfer vehicle. Proc Natl Acad Sci USA 1992; 89:7934-7938.
20. Kircheis R, Kichler A, Wallner G, Kursa M, Ogris M, Felzmann T, Buchberger M, Wagner E: Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 1997;4:409-418.
21. Pierschbacher MD, Ruoslahti E: Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984;309:30-33.
22. Lu X, Deadman JJ, Williams JA, Kakkar VV, Rahman S: Synthetic RGD peptides derived frorr the adhesive domains of snake venom proteins: Evaluation as inhibitors of platelet aggregation. Biochem J 1993;296:21-24.
23. Fox G, Parry NR, Barnett PV, McGinn B, Rowlands DJ, Brown F: The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol 1989;70:625-637.
24. Wang JH, Pepinsky RB, Stehle T, Liu JH, Karpusas M, Browning B, Osborn L: The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1): A cyclic peptide based on the domain 1 C-D loop can inhibit VCAM-1-alpha 4 integrin interaction. Proc Natl Acad Sci USA 1995;92:5714-5718.
25. Komoriya A, Green LJ, Mervic M, Yamada SS, Yamada KM, Humphries MJ: The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem 1991;266:15075-15079.
26. Mould AP, Komoriya A, Yamada KM, Humphries MJ: The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin alpha 4 beta 1. Inhibition of alpha 4 beta 1 function by RGD peptide homologues. J Biol Chem 1991;266:3579-3585.
27. Staatz WD, Fok KF, Zutter MM, Adams SP, Rodriguez BA, Santoro SA: Identification of a tetrapeptide recognition sequence for the a2b1 integrin in collagen. J Biol Chem 1991;266: 7363-7367.
28. Caniggia I, Liu J, Han R, Wang J, Tanswell AK, Laurie G, Post M: Identification of receptors binding fibronectin and laminin on fetal rat lung cells. Am J Physiol 1996;270:L459-L468.
29. Massia SP, Rao SS, Hubbell JA: Covalently immobilized laminin peptide Tyr-Ile-Gly-Ser-Arg (YIGSR) supports cell spreading and colocalization of the 67-kilodalton laminin receptor with alpha-actinin and vinculin. J Biol Chem 1993;268:8053-8059.
30. Healy JM, Murayama O, Maeda T, Yoshino K, Sekiguchi K, Kikuchi M: Peptide ligands for integrin alpha v beta 3 selected from random phage display libraries. Biochemistry 1995;34: 3948-3955.
31. Koivunen E, Gay DA, Ruoslahti E: Selection of peptides binding to the a5b1 integrin from phage display library. J Biol Chem 1993;268: 20205-20210.
32. Koivunen E, Wang B, Ruoslahti E: Isolation of a highly specific ligand for the a5b1 integrin from a phage display library. J Cell Biol 1994; 124:373-380.
33. Koivunen E, Wang B, Ruoslahti E: Phage libraries displaying cyclic peptides with different ring sizes: Ligand specificities of the RGD-directed integrins. Biotechnology 1995;13: 265-270.
34. O'Neil KT, Hoess RH, Jackson A, Ramachandran NS, Mousa A, DeGrado WF: Identification of novel peptide antagonists for GPIIb/ IIIa from a conformationally constrained phage peptide library. Proteins 1992;14:509-515.
35. Pasqualini R, Koivunen E, Ruoslahti E: A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J Cell Biol 1995;130: 1189-1196.
36. Pfaff M, Tangemann K, Müller B, Gurrath M, Müller G, Kessler H, Timpl R, Engel J: Selective recognition of cyclic RGD peptides of nmr defined conformation by aIIbb3, aVb3, and a5b1 integrins. J Biol Chem 1994;269: 20233-20238.
37. Greenwood J, Willis AE, Perham RN: Multiple display of foreign peptides on a filamentous bacteriophage: Peptides from Plasmodium falciparum circumsporozoite protein as antigens. J Mol Biol 1991;220:821-827.
38. Hart SL, Knight AM, Harbottle RP, Mistry A, Hunger H-D, Cutler DF, Williamson R, Coutelle C: Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J Biol Chem 1994; 269:12468-12474.
39. Hart SL, Harbottle RP, Cooper R, Miller A, Williamson R, Coutelle C: Gene delivery and expression mediated by an integrin-binding peptide. Gene Ther 1995;2:552-554.
40. Hart SL, Collins L, Gustaffsson K, Fabre JW: Integrin-mediated transfection with peptides containing arginine-glycine-aspartic acid domains. Gene Ther 1997;4:1225-1230.
41. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M: Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84:7413-7417.
42. Hart SL, Arancibia-Carcamo CV, Wolfert MA, Mailhos C, O'Reilly NJ, Ali RR, Coutelle C, George AJ, Harbottle RP, Knight AM, Larkin DF, Levinsky RJ, Seymour LW, Thrasher AJ, Kinnon C: Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum Gene Ther 1998;9:575-585.
43. Lobb RR, Hemler ME: The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest 1994;94:1722-1728.
44. Dransfield I, Cabanas C, Craig A, Hogg N: Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 1992; 116:219-226.
45. Roy-Chaudhury P, Hillis G, McDonald S, Simpson JG, Power DA: Importance of the tubulointerstitium in human glomerulonephritis. II. Distribution of integrin chains beta 1, alpha 1 to 6 and alpha V. Kidney Int 1997;52: 103-110.
46. Daikha-Dahmane F, Narcy F, Dommergues M, Lacoste M, Beziau A, Gubler MC: Distribution of alpha-integrin subunits in fetal polycystic kidney diseases. Pediatr Nephrol 1997;11: 267-273.
47. van Adelsberg J: Murine polycystic kidney epithelial cell lines have increased integrin-mediated adhesion to collagen. Am J Physiol 1994;267:F1082-F1093.
48. Rahilly MA, Fleming S: Abnormal integrin receptor expression in two cases of familial nephronophthisis. Histopathology 1995;26:345-349.
49. Varner JA, Cheresh DA: Integrins and cancer. Curr Opin Cell Biol 1996;8:724-730.
50. Pasqualani R, Ruoslahti E: Organ targeting in vivo using phage display peptide libraries. Nature 1996;380:364-366.
51. Pasqualini R, Koivunen E, Ruoslahti E: Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997;15: 542-546.
52. Ikeno M, Grimes B, Okazaki T, Nakano M, Saitoh K, Hoshino H, McGill NI, Cooke H, Masumoto H: Construction of YAC-based mammalian artificial chromosomes. Nat Biotechnol 1998;16:431-439.